We found that 6 mRNA expressions were significantly different (P<0.05), including GBP6 (guanylate binding protein), TMEM (transmembrane protein), CTCFL (liver cancer marker gene), KRT5 (keratin 5), LY6D (lymphocyte antigen) and TMEM179 (transmembrane protein). This evidence concerns the gene LY6D and liver cancer.